If Drug Distributors Can Coordinate Without Anti-Trust Concerns During The Coronavirus Pandemic, What About Generic Manufacturers?

Coronavirus dollar bill
Coordinated efforts among generic manufacturers may help prevent drug shortages, although under normal conditions such a move would raise anti-trust concerns. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics